MY157743A - Emulsion-type liquid composition for oral cavity and process for production thereof - Google Patents

Emulsion-type liquid composition for oral cavity and process for production thereof

Info

Publication number
MY157743A
MY157743A MYPI2012001873A MYPI2012001873A MY157743A MY 157743 A MY157743 A MY 157743A MY PI2012001873 A MYPI2012001873 A MY PI2012001873A MY PI2012001873 A MYPI2012001873 A MY PI2012001873A MY 157743 A MY157743 A MY 157743A
Authority
MY
Malaysia
Prior art keywords
emulsion
oral cavity
type liquid
liquid composition
composition
Prior art date
Application number
MYPI2012001873A
Inventor
Yamaguchi Tsubasa
Nomura Yasuo
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY157743A publication Critical patent/MY157743A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

DISCLOSED HEREIN IS AN EMULSION-TYPE LIQUID COMPOSITION FOR THE ORAL CAVITY, WHICH COMPRISES A LIQUID ORAL COMPOSITION SUBSTANTIALLY FREE OF ETHANOL THAT CONTAINS (A) ISOPROPYL METHYL PHENOL, (B) POLYOXYETHYLENE HYDROGENATED CASTOR OIL HAVING AN E.O. OF 40 TO 100 MOL, (C) (C-1) A DECAGLYCERIN MONOFATTY ACID ESTER AND (C-2) A TRIFATTY ACID GLYCERYL, AND (D) A POLYHYDRIC ALCOHOL SELECTED FROM GLYCERIN, PROPYLENE GLYCOL HAVING AN AVERAGE MOLECULAR WEIGHT OF 190 TO 630, WHEREIN THE [(B)+(C-1)]/[(C-2)] RATIO IS 0.77 TO 1.87 BY WEIGHT, THE COMPONENT (D) IS CONTAINED IN AN MOUNT OF 5 TO 15 WT%, AND GLYCERIN IS CONTAINED IN AN AMOUNT OF 0.003 WT% OR MORE. THE EMULSION TYPE LIQUID COMPOSITION HAS A HIGH INFILTRATION/STERILIZATION EFFECT ON A PERIODONTOPATHIC BIOFILM, ENABLES HIGH ACCUMULATION OF ISOPROPYL METHYL PHENOL IN THE ORAL CAVITY, AND HAS GOOD APPEARANCE STABILITY AND MILD IRRITATING PROPERTIES. ALSO DISCLOSED IS A PROCESS FOR PRODUCING THE COMPOSITION, WHICH INCLUDES MIXING THE COMPONENTS, (A), (B) AND (D) WITH ONE ANOTHER AND ADDING THE COMPONENT (C) IN THE FORM OF AN EMULSION TO THE RESULTING MIXTURE.
MYPI2012001873A 2009-12-22 2010-11-11 Emulsion-type liquid composition for oral cavity and process for production thereof MY157743A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009290242 2009-12-22

Publications (1)

Publication Number Publication Date
MY157743A true MY157743A (en) 2016-07-15

Family

ID=44195392

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012001873A MY157743A (en) 2009-12-22 2010-11-11 Emulsion-type liquid composition for oral cavity and process for production thereof

Country Status (6)

Country Link
JP (1) JP5690744B2 (en)
KR (1) KR101780837B1 (en)
CN (1) CN102655844B (en)
HK (1) HK1173960A1 (en)
MY (1) MY157743A (en)
WO (1) WO2011077847A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5953608B2 (en) * 2012-05-25 2016-07-20 日本ゼトック株式会社 Biofilm inhibitor
JP6331641B2 (en) * 2014-04-21 2018-05-30 ライオン株式会社 Liquid oral composition, method for producing the same, and method for stabilizing low temperature of allantoin or a derivative thereof in the composition
WO2015163284A1 (en) * 2014-04-21 2015-10-29 ライオン株式会社 Liquid composition for oral use and method for improving resilience to freezing thereof
JP6634284B2 (en) * 2015-12-25 2020-01-22 日油株式会社 Concentrated antimicrobial composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005179231A (en) * 2003-12-18 2005-07-07 Lion Corp Liquid composition for oral cavity
JP4873154B2 (en) * 2004-12-24 2012-02-08 ライオン株式会社 Liquid oral composition
JP2006182662A (en) * 2004-12-27 2006-07-13 Lion Corp Dentifrice composition
WO2007148551A1 (en) * 2006-06-23 2007-12-27 Lion Corporation Liquid oral composition containing isopropylmethylphenol

Also Published As

Publication number Publication date
CN102655844B (en) 2014-07-09
HK1173960A1 (en) 2013-05-31
CN102655844A (en) 2012-09-05
WO2011077847A1 (en) 2011-06-30
KR101780837B1 (en) 2017-09-21
JPWO2011077847A1 (en) 2013-05-02
JP5690744B2 (en) 2015-03-25
KR20120112538A (en) 2012-10-11

Similar Documents

Publication Publication Date Title
UA94052C2 (en) Pyridazine derivatives
RU2009138047A (en) VITAMIN B12 STABILIZATION
MX2007013084A (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof.
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
ATE527985T1 (en) COMPOSITIONS FOR SKIN LIGHTENING
CA2757418C (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
WO2006113631A3 (en) Bioenhanced compositions
WO2009100441A3 (en) Depot formulations
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
MY157743A (en) Emulsion-type liquid composition for oral cavity and process for production thereof
MY157740A (en) Liquid oral composition and method for producing same
MY139522A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
CY1116490T1 (en) KLEVIDIPIN PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING CONCENTRATING LOW PRIMARY CONCENTRATIONS
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
PL1718679T3 (en) Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same
WO2011146583A3 (en) Nanoparticulate cinacalcet formulations
MX2011010415A (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof.
WO2013117770A3 (en) Cosmetic treatment method, and composition comprising a glyoxylic acid ester
WO2009015856A3 (en) Phosphoric acid esters containing phosphorus atoms bridged by diol units
SI1608346T1 (en) Alpha-hydroxy acid ester drug delivery compositions and methods of use
CA2798180A1 (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
TW200616616A (en) Paclitaxel aqueous injection solution and methods for preparing the same
HK1108633A1 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
PL2021002T3 (en) Pharmaceutical composition comprising olmesartan medoxomil